Business Wire | Aug 25, 2020 12:14PM EDT

Nanox Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Aug. 25, 2020

NEVE ILAN, Israel--(BUSINESS WIRE)--Aug. 25, 2020--NANO-X IMAGING LTD ("Nanox" or the "Company"), an innovative medical imaging technology company, announced today the closing of its initial public offering of 10,555,556 ordinary shares, which includes the full exercise of the underwriters' option to purchase 1,376,812 additional ordinary shares at a public offering price of US$18.00 per share. The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Nanox, were US$190.0 million. All of the shares were offered by Nanox. The shares began trading on the Nasdaq Global Market under the ticker symbol "NNOX" on August 21, 2020.

Cantor Fitzgerald & Co., Oppenheimer & Co. Inc., Berenberg and CIBC Capital Markets acted as joint book-runners. National Securities Corporation acted as co-manager for the offering.

A registration statement, including a prospectus, on Form F-1 relating to these securities has been filed with, and declared effective by, the Securities and Exchange Commission. The offerings were made only by means of a prospectus. Copies of the final prospectus may be obtained by contacting: Cantor Fitzgerald & Co., Attention: Capital Markets, 499 Park Ave., 6th Floor, New York, New York 10022, or by email at prospectus@cantor.com, Oppenheimer & Co. Inc., Attention: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, New York 10004, by telephone at (212) 667-8055, or by email at EquityProspectus@opco.com, Berenberg Capital Markets, LLC, Attention: Equity Capital Markets, 1251 Avenue of the Americas, 53rd Floor, New York, NY 10020, telephone: (646) 949-9000, or CIBC Capital Markets, 425 Lexington Avenue, 5th floor, New York, NY, by telephone at (800) 282-0822, or by email at useprospectus@cibc.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200825005756/en/

CONTACT: IR contacts: Bob Yedid LifeSci Advisors, LLC 646-597-6989 bob@lifesciadvisors.com

CONTACT: Itzhak Maayan, CFO at Nanox IR@nanox.vision

CONTACT: Media Contact: Alona Stein ReBlonde for Nanox alona@reblonde.com